Iovance Biotherapeutics Statistics
Total Valuation
IOVA has a market cap or net worth of $6.62 billion. The enterprise value is $6.37 billion.
| Market Cap | 6.62B |
| Enterprise Value | 6.37B |
Important Dates
The next estimated earnings date is Thursday, November 5, 2026, before market open.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
IOVA has 452.97 million shares outstanding. The number of shares has increased by 29.62% in one year.
| Current Share Class | 452.97M |
| Shares Outstanding | 452.97M |
| Shares Change (YoY) | +29.62% |
| Shares Change (QoQ) | +7.57% |
| Owned by Insiders (%) | 6.56% |
| Owned by Institutions (%) | 58.07% |
| Float | 394.31M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 20.67 |
| Forward PS | 13.01 |
| PB Ratio | 9.15 |
| P/TBV Ratio | 14.23 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 19.90 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.35, with a Debt / Equity ratio of 0.06.
| Current Ratio | 4.35 |
| Quick Ratio | 3.74 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -40.36% and return on invested capital (ROIC) is -24.14%.
| Return on Equity (ROE) | -40.36% |
| Return on Assets (ROA) | -20.31% |
| Return on Invested Capital (ROIC) | -24.14% |
| Return on Capital Employed (ROCE) | -36.62% |
| Weighted Average Cost of Capital (WACC) | 8.35% |
| Revenue Per Employee | $333,302 |
| Profits Per Employee | -$296,941 |
| Employee Count | 975 |
| Asset Turnover | 0.36 |
| Inventory Turnover | 3.18 |
Taxes
| Income Tax | -4.26M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +530.17% in the last 52 weeks. The beta is 0.76, so IOVA's price volatility has been lower than the market average.
| Beta (5Y) | 0.76 |
| 52-Week Price Change | +530.17% |
| 50-Day Moving Average | 10.61 |
| 200-Day Moving Average | 5.48 |
| Relative Strength Index (RSI) | 64.23 |
| Average Volume (20 Days) | 16,687,596 |
Short Selling Information
The latest short interest is 64.83 million, so 14.31% of the outstanding shares have been sold short.
| Short Interest | 64.83M |
| Short Previous Month | 87.13M |
| Short % of Shares Out | 14.31% |
| Short % of Float | 16.44% |
| Short Ratio (days to cover) | 3.69 |
Income Statement
In the last 12 months, IOVA had revenue of $324.97 million and -$289.52 million in losses. Loss per share was -$0.71.
| Revenue | 324.97M |
| Gross Profit | 157.29M |
| Operating Income | -296.17M |
| Pretax Income | -293.78M |
| Net Income | -289.52M |
| EBITDA | -259.60M |
| EBIT | -296.17M |
| Loss Per Share | -$0.71 |
Balance Sheet
The company has $297.67 million in cash and $46.00 million in debt, with a net cash position of $251.67 million or $0.56 per share.
| Cash & Cash Equivalents | 297.67M |
| Total Debt | 46.00M |
| Net Cash | 251.67M |
| Net Cash Per Share | $0.56 |
| Equity (Book Value) | 736.05M |
| Book Value Per Share | 1.62 |
| Working Capital | 357.41M |
Cash Flow
In the last 12 months, operating cash flow was -$264.18 million and capital expenditures -$32.21 million, giving a free cash flow of -$296.40 million.
| Operating Cash Flow | -264.18M |
| Capital Expenditures | -32.21M |
| Depreciation & Amortization | 36.56M |
| Net Borrowing | n/a |
| Free Cash Flow | -296.40M |
| FCF Per Share | -$0.65 |
Margins
Gross margin is 48.40%, with operating and profit margins of -91.14% and -89.09%.
| Gross Margin | 48.40% |
| Operating Margin | -91.14% |
| Pretax Margin | -90.40% |
| Profit Margin | -89.09% |
| EBITDA Margin | -79.89% |
| EBIT Margin | -91.14% |
| FCF Margin | n/a |
Dividends & Yields
IOVA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -29.62% |
| Shareholder Yield | -29.62% |
| Earnings Yield | -4.83% |
| FCF Yield | -4.41% |
Analyst Forecast
The average price target for IOVA is $14.40, which is -1.50% lower than the current price. The consensus rating is "Buy".
| Price Target | $14.40 |
| Price Target Difference | -1.50% |
| Analyst Consensus | Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (3Y) | 51.77% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 26, 2013. It was a reverse split with a ratio of 1:100.
| Last Split Date | Sep 26, 2013 |
| Split Type | Reverse |
| Split Ratio | 1:100 |
Scores
IOVA has an Altman Z-Score of -0.81 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.81 |
| Piotroski F-Score | 4 |